CRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Asociación para el Desarrollo de la Investigación Estudiantil en Ciencias de la Salud (ADIECS), Lima, Peru.
J Diabetes Sci Technol. 2021 Nov;15(6):1390-1393. doi: 10.1177/1932296820952065. Epub 2020 Aug 29.
Transparency is a key factor to understand how recommendations were reached and to decide whether to adopt them or not. Currently, the American Diabetes Association (ADA) recommends the usage of real-time continuous glucose monitors in certain subgroups of people living with type 1 diabetes mellitus. In this commentary we sought to critically appraise this recommendation, mainly regarding the outcomes assessed, the evidence used for each outcome, and how the balance of benefits and harms was made. We found that the decision-making process followed to reach the ADA recommendation was not clear, and that the final recommendation does not seem to be supported in the assessed evidence.
透明度是了解建议如何达成以及决定是否采用这些建议的关键因素。目前,美国糖尿病协会(ADA)建议在某些类型 1 糖尿病患者亚组中使用实时连续血糖监测仪。在本评论中,我们主要针对评估的结果、每个结果使用的证据以及如何权衡利弊,对这一建议进行批判性评估。我们发现,达成 ADA 建议的决策过程不明确,而且评估的证据似乎不支持最终的建议。